Profound Medical Corp. — Investor Relations & Filings
Filings indexed
659
across all filing types
Latest filing
2025-09-23
Regulatory Filings
Country
CA
Canada
Listing
TSX
PROF
Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2025-09-23 | English | |
| News release - English.pdf | 2025-08-28 | English | |
| 52-109F2 - Certification of interim filings - CEO (E).pdf | 2025-08-14 | English | |
| Interim financial statements/report – English.pdf | 2025-08-14 | English | |
| News release - English.pdf | 2025-08-14 | English | |
| News release - English.pdf | 2025-07-24 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 47434820 | News release - English.pdf | 2025-09-23 | English | ||
| 47434824 | News release - English.pdf | 2025-08-28 | English | ||
| 47434848 | 52-109F2 - Certification of interim filings - CEO (E).pdf | 2025-08-14 | English | ||
| 47434860 | Interim financial statements/report – English.pdf | 2025-08-14 | English | ||
| 47434864 | News release - English.pdf | 2025-08-14 | English | ||
| 47434868 | News release - English.pdf | 2025-07-24 | English | ||
| 47434893 | News release - English.pdf | 2025-06-04 | English | ||
| 47434922 | Report of voting results.pdf | 2025-05-14 | English | ||
| 47434926 | News release - English.pdf | 2025-05-14 | English | ||
| 13791480 | 52-109F2 - Certification of interim filings - CEO (E).pdf | 2025-05-08 | English | ||
| 13791461 | Interim financial statements/report – English.pdf | 2025-05-08 | English | ||
| 13791460 | Other.pdf | 2025-05-08 | English | ||
| 13791458 | Interim MD&A - English.pdf | 2025-05-08 | English | ||
| 13791456 | 52-109F2 - Certification of interim filings - CFO (E).pdf | 2025-05-08 | English | ||
| 13791477 | News release - English.pdf | 2025-05-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of medical and dental instruments and supplies
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
3-D Matrix,Ltd.
Develops peptide-based hydrogels to control bleeding in sur…
|
7777 | JP | Manufacturing |
|
aap Implantate AG
Develops, manufactures, and markets implants for the treatm…
|
AAQ1 | DE | Manufacturing |
|
ABATE AS INDUSTRIES LIMITED
Manufactures therapeutic footwear and wellness products for…
|
531658 | IN | Manufacturing |
|
Acotec Scientific Holdings Limited
Interventional medical device company developing innovative…
|
6669 | KY | Manufacturing |
|
AcouSort AB
Develops acoustofluidic solutions for automated biological …
|
ACOU | SE | Manufacturing |
|
Adagio Medical Holdings, Inc.
Develops cryoablation technologies for treating cardiac arr…
|
ADGM | US | Manufacturing |
|
ADVANCED MEDICAL SOLUTIONS GROUP PLC
Develops and manufactures innovative tissue-healing technol…
|
AMS | GB | Manufacturing |
|
AETHLON MEDICAL INC
Develops immunotherapeutic devices to deplete exosomes and …
|
AEMD | US | Manufacturing |
|
Affluent Medical
Develops minimally invasive implants for structural heart d…
|
AFME | FR | Manufacturing |
|
Aidite (Qinhuangdao) Technology Co., Ltd.
Develops and manufactures dental materials, zirconia cerami…
|
301580 | CN | Manufacturing |
Profound Medical Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47229/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47229 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47229 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47229 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47229}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Profound Medical Corp. (id: 47229)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.